Lipid Management in Clinical Practice

Trial Profile

Lipid Management in Clinical Practice

Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs Niacin/laropiprant (Primary)
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 06 Mar 2012 Actual patient number (2390) added as reported by
    • 06 Mar 2012 Actual end date changed from Dec 2010 to Feb 2011 as reported by
    • 11 Apr 2011 Status changed from active, no longer recruiting to completed as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top